What is the recommended prescribing regimen for topical urea cream in hyperkeratosis?

Prescribing Urea Cream for Hyperkeratosis

For hyperkeratosis, prescribe urea cream at ≥10% concentration applied once or twice daily, with concentrations up to 20-40% for localized areas of thick hyperkeratosis such as palms, soles, or joints, and taper frequency as the condition improves. 1

Concentration Guidelines

The concentration of urea should be matched to the severity and location of hyperkeratosis:

• Standard hyperkeratosis: Start with ≥10% urea for effective keratolysis 1, 2
• Localized thick hyperkeratosis: Use 20-40% urea for areas like joints, palms, soles, or palmoplantar keratoderma 1, 2
• Maintenance: Taper application frequency once improvement is achieved 1

The FDA labeling confirms urea 40% is indicated specifically for hyperkeratotic conditions including dry rough skin, dermatitis, psoriasis, xerosis, ichthyosis, keratosis pilaris, keratoderma, corns and calluses 3.

Application Regimen

Apply once or twice daily to affected areas 1, 3. The FDA label for 40% urea specifically recommends twice-daily application, rubbed in until completely absorbed 3. You can reduce frequency based on clinical response—this is not a fixed regimen but should be adjusted as scales and hyperkeratosis improve 1, 2.

Critical Age-Related Safety Restrictions

Urea has strict contraindications in young children due to toxicity risk:

• Neonatal period: Do NOT use urea except on very limited areas (palms/soles only) 1
• Under 6-12 months: Relatively contraindicated due to epidermal barrier defects, immature stratum corneum, and higher body-surface-to-mass ratio increasing systemic absorption 1
• Under 1 year: Not recommended for ≥10% urea except once daily on limited areas like palms and soles 2
• 1-2 years: Restrict to once daily application on limited areas for older children 2

The 2025 guideline update emphasizes that high blood urea concentrations have been documented after cutaneous application of 10% urea in collodion babies and infants with lamellar ichthyosis, though no frank toxicity from urea has been reported in children (unlike salicylic acid and lactic acid which have caused life-threatening toxicity) 1.

Application Site Precautions

Avoid or use cautiously on:

• Face, flexures, and areas of fissuring—these sites are prone to irritation, burning, and itching 1, 2
• Protect fissures and surrounding skin with petroleum jelly before application, particularly when using higher concentrations 2

Mechanism and Expected Outcomes

Urea dissolves the intracellular matrix, loosening the horny layer and promoting shedding of scaly skin, thereby softening hyperkeratotic areas 3. Studies demonstrate superiority over emollients alone in removing scales and hyperkeratosis 1, 2. Clinical improvement typically shows:

• Significant reduction in skin thickness and hyperkeratosis within 1-4 weeks 4, 5
• In psoriatic plaques, 92% clinical clearance of hyperkeratosis by day 21, with 36% clear by day 7 5

Practical Prescribing Approach

1. Initial prescription: Start with 10-20% urea cream twice daily for generalized hyperkeratosis
2. Localized thick areas: Prescribe 40% urea for palms, soles, elbows, knees
3. Combination strategy: Can be used as monotherapy or combined with oral retinoids for severe cases 2
4. Patient counseling: Warn about potential irritation (itching, burning sensation), especially on sensitive areas 1, 2
5. Follow-up: Reassess at 2-4 weeks and taper to once daily or less frequent application based on response

Common Pitfall

The most critical error is using urea in infants without recognizing the age-related toxicity risk. While urea appears safer than salicylic acid or lactic acid (which are strictly contraindicated under age 2), the immature skin barrier in young children creates real risk of systemic absorption 1. Always verify patient age before prescribing concentrations ≥10%.